Hormone replacement therapy, prothrombotic mutations, and the risk of incident non-fatal myocardial infarction

Frits R. Rosendaal

Related publications

Letter2002

Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Ischemic Stroke in Postmenopausal Women

Rozenn N. Lemaître, Bruce M. Psaty, Susan R. Heckbert, Nicholas L. Smith, W. T. Longstreth, Frits R. Rosendaal

Arteriosclerosis Thrombosis and Vascular Biology

Article2019

CORE LABORATORY ASSESSMENT OF NON-FATAL Q-WAVE MYOCARDIAL INFARCTION IN THE GLOBAL LEADERS TRIAL: METHODS AND FINDINGS

Ernest Spitzer Cano, Ply Chichareon, Eugène McFadden, Rodrigo Modolo, Kuniaki Takahashi, Chun‐Chin Chang, Norihiro Kogame, Yuki Katagiri, Stephen P. Hoole, Tommaso Gori, Azfar Zaman, Bernhard Frey, Rui Cruz Ferreira, Olivier Bertrand, Sing‐Chien Yap, Philippe Steg, Christian W. Hamm, Peter Jüni, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Patrick W. Serruys, Yoshinobu Onuma, Osama Soliman

Journal of the American College of Cardiology

Letter2004

No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors

Chris H. Martini, Carine J.M. Doggen, Claudio Cavallini, Frits R. Rosendaal, Pier Mannuccio Mannucci

Journal of Thrombosis and Haemostasis

Article2002

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis

Frits R. Rosendaal, Martin Vessey, Ann Rumley, Eman F. El-Daly, Mark Woodward, Frans M. Helmerhorst, Gordon Lowe

British Journal of Haematology

Article2005

Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy

Alessandra Tavani, Michaela Bertuzzi, Silvano Gallus, Eva Negri, Carlo La Vecchia